Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Vascular Function, Racial Disparity
Interventions: Dietary Nitrates 400 mg, L-citrulline 3 g, Sildenafil 100 mg, Bosentan 125 mg; Dietary Supplement · Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: SedLine EEG, RRa monitoring; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 19 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chordoma, Locally Advanced Chordoma, Metastatic Chordoma, Unresectable Chordoma
Interventions: Nivolumab, Relatlimab; Biological
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 12 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Otitis Media Recurrent, Middle Ear Infection, Ear Infection
Interventions: Advanced Ultrasound Otoscope; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 0 Years to 12 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Melanoma, Sentinel Node
Interventions: Indocyanine green, Technetium99, Methylene blue; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Hepatocellular Cancer, Colorectal Cancer, Gastric Adenocarcinoma, Melanoma, Advanced Cancer
Interventions: TTI-101; Drug
Lead sponsor: Tvardi Therapeutics, Incorporated; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Houston, Texas • San Antonio, Texas

Conditions: General Menstrual Discomfort
Interventions: Jovi Patch, Sham Patch; Device
Lead sponsor: Signal Relief; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Meadowbrook, Pennsylvania

Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Cancer, Poorly Differentiated Neuroendocrine Carcinomas, Homologous Recombination Deficient-Positive Malignancies Agnostic
Interventions: Lurbinectedin; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 17
States / cities: Stanford, California • Norwich, Connecticut • Fort Myers, Florida + 14 more

Conditions: Seasonal Affective Disorder, Mood Disorders, Depression
Interventions: bright light box, dawn simulator, high-output negative ion generator, low-output negative ion generator, dawn light pulse; Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism Spectrum Disorders
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years to 25 Years
Enrollment: 213 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Fossa Ependymoma
Interventions: 5-Azacytidine and trastuzumab infusion; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 1 Year to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Speech Sound Disorder
Interventions: Traditional articulation treatment, Visual-acoustic biofeedback; Behavioral
Lead sponsor: New York University; Other
Eligibility: 8 Years to 15 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcohol Abuse
Interventions: Alcohol, Saline; Drug
Lead sponsor: Mark Fillmore; Other
Eligibility: 21 Years to 29 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Carotid Stenosis, Femoral Arterial Stenosis, Carotid Bruit Asymptomatic, Carotid Murmur
Interventions: AudioDoc; Device
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 19 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lymphedema of Face, Head and Neck Cancer
Interventions: Near-infrared fluorescence lymphatic imaging, advanced pneumatic compression therapy; Combination Product · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gestational Diabetes Mellitus, Hypertension in Pregnancy, Dysglycemia
Interventions: OB Provider Clinical Decision Support (CDS), Patient Education (OB Visit), Text messaging, Patient Outreach, Primary Care Provider Clinical Decision Support (CDS), Patient Education (Primary Care Visit); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: PTSD, Anxiety, Trauma, Sleep Disorders
Interventions: EEG biofeedback; Device
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: San Diego, California

Conditions: Type 1 Diabetes
Interventions: Medtronic MiniMed Closed Loop (CL) System, Snacking; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 44 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: PROSTVAC-V, PROSTVAC-F, Nivolumab, Ipilimumab, Neoantigen DNA vaccine, TriGrid Delivery System, Tumor biopsy, Peripheral blood, Fecal samples, Leukapheresis; Biological · Drug · Device + 1 more
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Healthy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Focus is on Healthy Subjects
Interventions: measure ascending aortic blood flow with pulse wave Doppler; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Asthma in Children, Obesity, Pediatric Obesity, Pediatric Asthma
Interventions: Pro2 - Low Dose - 40% of participant's MIP, Pro2 - High Dose - 75% of participant's MIP, Pro2 - SHAM - 15% of participant's MIP; Device
Lead sponsor: Duke University; Other
Eligibility: 6 Years to 17 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Healthy Normals
Interventions: Physiological signal monitor, Heart rate and heart rate variability comparison device, Respiration rate comparison device, Activity classification; Device · Other
Lead sponsor: MC10 Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Blood Pressure Measurement
Interventions: Sensifree's Alpha sensor, Arrow® arterial catheterization kit (Teleflex), GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor; Device
Lead sponsor: Sensifree Ltd.; Industry
Eligibility: 20 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Louisville, Colorado

Search by objective public record fields.

Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1

Correlation Endoscopic View of Airway Obstruction With RRa in OSA Patients Under DEX Monitored With SedLine EEG

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM

Infrared Lymphangiography as a Method of Sentinel Node Identification

Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers

A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort

Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Extracellular Signal-Related Kinase Biomarker Development in Autism

Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults with Recurrent or Residual Posterior Fossa Ependymoma

staRt: Enhancing Speech Treatment With Smartphone-delivered Biofeedback

Sex Differences in Risk for Alcohol Abuse

Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis

Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

EEG Biofeedback Therapy as an Adjunct Treatment for PTSD

Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Positron Emission Tomography (PET) to Study Brain Signaling

Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity

Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)

Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data

Evaluation of Sensifree's Alpha Sensor Signal Morphology Compared to Arterial Line and PPG Signal Morphologies